Berlin / New York - October 30, 2025 - We’re excited to share some big news: In collaboration with NEJM Group, we are launching a new series of online courses designed to help clinicians bridge the gap between high-impact medical research and clinical practice. The basis of the course content is evidence from the New England Journal of Medicine, a publication of NEJM Group, presented alongside AMBOSS’s comprehensive medical expertise and innovative learning design.

‍

For decades, the New England Journal of Medicine has set the standard for excellence in medical research. AMBOSS gives clinicians the tools to apply evidence where it matters most: patient care. We are both driven by a shared passion for developing clinically focused learning and trusted medical knowledge. 

‍

Today, we are announcing our first two courses: From Evidence to Impact – Translating Latest Research into Clinical Care and Core Concepts in Clinical Research. Our mission is as simple as it is impactful: Learn from the world’s leading experts how research is conducted and its implications for clinical practice.

‍

“We are pleased to work with AMBOSS on the development of these two forward-thinking courses that reflect our shared commitment to fostering excellence in medical education and delivering meaningful learning opportunities that support a diverse range of health care professionals.”

• Eric Rubin, NEJM Editor-in-Chief 

‍

“Working with NEJM Group allows us to combine the gold standard in medical research with AMBOSS’s expertise in transforming knowledge into practice. Together, we’re empowering clinicians to master research concepts and deliver care that’s truly evidence-driven. We are really proud of this powerful collaboration.”

• Madjid Salimi, AMBOSS CEO & Co-Founder